Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients

被引:114
作者
Dupont, H
Paugam-Burtz, C
Muller-Serieys, C
Fierobe, L
Chosidow, D
Marmuse, JP
Mantz, J
Desmonts, JM
机构
[1] Univ Hosp Bichat Claude Bernard, Dept Anesthesiol, Paris, France
[2] Univ Hosp Bichat Claude Bernard, Surg Intens Care Unit, Paris, France
[3] Univ Hosp Bichat Claude Bernard, Dept Microbiol, Paris, France
[4] Univ Hosp Bichat Claude Bernard, Dept Gen Surg, Paris, France
关键词
D O I
10.1001/archsurg.137.12.1341
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Candida peritonitis (CP) is generally considered to be a severe disease, but its impact on outcome in critically ill patients remains unknown. Hypothesis: The predictive factors of mortality due to CP can be determined by study of a, population of patients with CP. Design: A retrospective review of a prospective surgical intensive care unit (ICU) database of patients (January 1, 1994, through December 31, 2000). Setting: University hospital in Paris, France. Patients: Eighty-three patients with generalized CP. Main Outcome Measures: Demographic and microbiologic data and outcome were collected, and nonsurvivors were compared with survivors. Results: Overall ICU mortality due to CP was 43 (52%) of 83 patients. In a stepwise multivariate logistic regression, the following 4 variables were independently associated with mortality: APACHE II (Acute Physiology and Chronic Health Evaluation 11) score on admission of at least 17 (odds ratio [OR], 28.4; 95% confidence interval [CI], 5.7-142.5; P < .001), respiratory failure on admission (OR, 10.6; 95% CI, 2.2-51.2; P = .003), upper gastrointestinal tract site of peritonitis (OR, 7.7; 95% CI, 1.7-34.7; P = .007), and results of direct examination of peritoneal fluid that were positive for Candida (OR, 4.7; 95% CI, 1.2-19.7; P = .0.02). Conclusions: These results confirm the severity of CP in ICU patients and emphasize the prognostic value of direct examination of peritoneal fluid for Candida in this context.
引用
收藏
页码:1341 / 1346
页数:6
相关论文
共 38 条
[1]  
ALDEN SM, 1989, AM SURGEON, V55, P45
[2]   Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature [J].
Anaissie, EJ ;
Darouiche, RO ;
AbiSaid, D ;
Uzun, O ;
Mera, J ;
Gentry, LO ;
Williams, T ;
Kontoyiannis, DP ;
Karl, CL ;
Bodey, GP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :964-972
[3]   CANDIDA PERITONITIS - REPORT OF 22 CASES AND REVIEW OF ENGLISH LITERATURE [J].
BAYER, AS ;
BLUMENKRANTZ, MJ ;
MONTGOMERIE, JZ ;
GALPIN, JE ;
COBURN, JW ;
GUZE, LB .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (06) :832-839
[4]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[5]  
CALANDRA T, 1989, LANCET, V2, P1437, DOI 10.1016/S0140-6736(89)92043-6
[6]  
CHRISTOU NV, 1993, ARCH SURG-CHICAGO, V128, P193
[7]   Randomized, controlled trials, observational studies, and the hierarchy of research designs. [J].
Concato, J ;
Shah, N ;
Horwitz, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1887-1892
[8]   Gallbladder and biliary tract candidiasis [J].
Diebel, LN ;
Raafat, AM ;
Dulchavsky, SA ;
Brown, WJ .
SURGERY, 1996, 120 (04) :760-764
[9]   International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections [J].
Edwards, JE ;
Bodey, GP ;
Bowden, RA ;
Buchner, T ;
dePauw, BE ;
Filler, SG ;
Ghannoum, MA ;
Glauser, M ;
Herbrecht, R ;
Kauffman, CA ;
Kohno, S ;
Martino, P ;
Meunier, F ;
Mori, T ;
Pfaller, MA ;
Rex, JH ;
Rogers, TR ;
Rubin, RH ;
Solomkin, J ;
Viscoli, C ;
Walsh, TJ ;
White, M .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :43-59
[10]  
Grunau G, 1996, EUR J SURG, V162, P619